From a trial of an antibody that helps the immune system to recognise and attack cancer cells, new results have shown particularly encouraging responses in patients who are smokers or former smokers. Presenting the most up-to-date data from 85 patients with non-small cell lung cancer in a large, phase I clinical trial of an experimental drug called MPDL3280A, Professor Jean-Charles Soria told the 2013 European Cancer Congress (ECC2013) [1] today (Sunday): "This ...
via Medindia Health News
More READ
No comments:
Post a Comment